News & Updates

Selexipag demonstrates therapeutic potential in systemic sclerosis vasculopathy

08 Feb 2025

Preliminary data from an observational case–control study have shown that selexipag is safe and effective in the treatment of systemic sclerosis vasculopathy, particularly digital ulcers (DUs) and Raynaud phenomenon (RP).

Selexipag demonstrates therapeutic potential in systemic sclerosis vasculopathy

08 Feb 2025

Routine vaccines linked to higher risk of apnoea in hospitalized preterm infants

08 Feb 2025 by

Hospitalized preterm infants who received routine 2-month vaccinations were more likely to experience an apnoea episode within 48 hours than those who did not receive any vaccinations, according to a recent study.

Routine vaccines linked to higher risk of apnoea in hospitalized preterm infants

08 Feb 2025

Functional outcome after IVT not significantly improved with remote ischaemic conditioning

07 Feb 2025

In the treatment of patients with acute ischaemic stroke who underwent intravenous thrombolysis (IVT), remote ischaemic conditioning does not appear to increase the chances of achieving excellent functional outcome, according to a study.

Functional outcome after IVT not significantly improved with remote ischaemic conditioning

07 Feb 2025

Hybrid closed-loop insulin system keeps blood sugar in check from pregnancy to postpartum

07 Feb 2025 by

For pregnant women with type 1 diabetes (T1D), continued use of hybrid-closed loop (HCL) insulin through the postpartum period appears to be safe and efficacious, helping maintain blood sugar control for a significant portion of the time without an increase in hypoglycaemia.

Hybrid closed-loop insulin system keeps blood sugar in check from pregnancy to postpartum

07 Feb 2025

Multidisciplinary clinics improve vascular access, outcomes in haemodialysis patients

07 Feb 2025 by

Implementing multidisciplinary care among patients undergoing haemodialysis results in significant increases in the use of definitive vascular access and reductions in intensive care unit (ICU) admissions and recurrent hospitalizations, reports a Singapore study.

Multidisciplinary clinics improve vascular access, outcomes in haemodialysis patients

07 Feb 2025

Heavy cannabis use among young adults can mess with working memory

07 Feb 2025

A lifetime history of heavy cannabis use among young adults appears to exert a long-lasting detrimental effect on working memory, according to a cross-sectional study.

Heavy cannabis use among young adults can mess with working memory

07 Feb 2025

New clue to SIDS: Metabolic signatures identified

06 Feb 2025 by

A group of researchers has discovered distinct metabolic signatures that may be linked to sudden infant death syndrome (SIDS), raising the possibility of developing biomarkers to aid prediction and diagnosis of the condition.

New clue to SIDS: Metabolic signatures identified

06 Feb 2025

Gabapentin relieves paclitaxel-induced neuropathic pain

06 Feb 2025

The use of gabapentin is effective in reducing neuropathic pain due to paclitaxel chemotherapy, as shown in a study.

Gabapentin relieves paclitaxel-induced neuropathic pain

06 Feb 2025

Three biologic classes beneficial for severe allergic asthma with nasal polyps in real world

06 Feb 2025

All biologic classes—anti-IgE, anti-IL5/R, and anti-IL4R—help improve outcomes in patients with severe allergic asthma with nasal polyps treated in real-world settings, according to a study. However, anti-IL4R bests the other two in terms of improving the smell, nasal obstruction, and nasal polyp endoscopic size.

Three biologic classes beneficial for severe allergic asthma with nasal polyps in real world

06 Feb 2025

Schizophrenia: Clozapine a better fit for second relapse prevention

06 Feb 2025 by

A population-based cohort study in Finland has revealed that clozapine initiation after a first-episode schizophrenia relapse is associated with a lower risk of second relapse compared with continuation with the same antipsychotic or switching to another non-clozapine oral antipsychotic. These findings challenge current guidelines that recommend clozapine as a third-line treatment.

Schizophrenia: Clozapine a better fit for second relapse prevention

06 Feb 2025

News & Updates

Filter by Specialty:

Specialty:

Selexipag demonstrates therapeutic potential in systemic sclerosis vasculopathy

Selexipag demonstrates therapeutic potential in systemic sclerosis vasculopathy

Routine vaccines linked to higher risk of apnoea in hospitalized preterm infants

Routine vaccines linked to higher risk of apnoea in hospitalized preterm infants

Functional outcome after IVT not significantly improved with remote ischaemic conditioning

Functional outcome after IVT not significantly improved with remote ischaemic conditioning

Hybrid closed-loop insulin system keeps blood sugar in check from pregnancy to postpartum

Hybrid closed-loop insulin system keeps blood sugar in check from pregnancy to postpartum

Multidisciplinary clinics improve vascular access, outcomes in haemodialysis patients

Multidisciplinary clinics improve vascular access, outcomes in haemodialysis patients

Heavy cannabis use among young adults can mess with working memory

Heavy cannabis use among young adults can mess with working memory

New clue to SIDS: Metabolic signatures identified

New clue to SIDS: Metabolic signatures identified

Gabapentin relieves paclitaxel-induced neuropathic pain

Gabapentin relieves paclitaxel-induced neuropathic pain

Three biologic classes beneficial for severe allergic asthma with nasal polyps in real world

Three biologic classes beneficial for severe allergic asthma with nasal polyps in real world

Schizophrenia: Clozapine a better fit for second relapse prevention

Schizophrenia: Clozapine a better fit for second relapse prevention